232 related articles for article (PubMed ID: 36125528)
1. Role of cathepsin B of Naegleria fowleri during primary amebic meningoencephalitis.
Rodríguez-Mera IB; Carrasco-Yépez MM; Vásquez-Moctezuma I; Correa-Basurto J; Salinas GR; Castillo-Ramírez DA; Rosales-Cruz É; Rojas-Hernández S
Parasitol Res; 2022 Nov; 121(11):3287-3303. PubMed ID: 36125528
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of monoclonal antibodies against cathepsin B and cathepsin B-Like proteins of Naegleria fowleri.
Seong GS; Sohn HJ; Kang H; Seo GE; Kim JH; Shin HJ
Exp Parasitol; 2017 Dec; 183():171-177. PubMed ID: 28919331
[TBL] [Abstract][Full Text] [Related]
3. Novel cathepsin B and cathepsin B-like cysteine protease of Naegleria fowleri excretory-secretory proteins and their biochemical properties.
Lee J; Kim JH; Sohn HJ; Yang HJ; Na BK; Chwae YJ; Park S; Kim K; Shin HJ
Parasitol Res; 2014 Aug; 113(8):2765-76. PubMed ID: 24832815
[TBL] [Abstract][Full Text] [Related]
4. Fowlerstefin, a cysteine protease inhibitor of Naegleria fowleri, induces inflammatory responses in BV-2 microglial cells in vitro.
Thái TL; Kang JM; Lê HG; Lee J; Yoo WG; Shin HJ; Sohn WM; Na BK
Parasit Vectors; 2020 Jan; 13(1):41. PubMed ID: 31996242
[TBL] [Abstract][Full Text] [Related]
5. An In Vitro Model of the Blood-Brain Barrier: Naegleria fowleri Affects the Tight Junction Proteins and Activates the Microvascular Endothelial Cells.
Coronado-Velázquez D; Betanzos A; Serrano-Luna J; Shibayama M
J Eukaryot Microbiol; 2018 Nov; 65(6):804-819. PubMed ID: 29655298
[TBL] [Abstract][Full Text] [Related]
6. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
[TBL] [Abstract][Full Text] [Related]
7. Identification of Naegleria fowleri proteins linked to primary amoebic meningoencephalitis.
Jamerson M; Schmoyer JA; Park J; Marciano-Cabral F; Cabral GA
Microbiology (Reading); 2017 Mar; 163(3):322-332. PubMed ID: 28086072
[TBL] [Abstract][Full Text] [Related]
8. Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.
Zhang LL; Wu M; Hu BC; Chen HL; Pan JR; Ruan W; Yao LN
Int J Infect Dis; 2018 Jul; 72():28-33. PubMed ID: 29751112
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants.
Lee J; Yoo JK; Sohn HJ; Kang HK; Kim D; Shin HJ; Kim JH
Parasitol Res; 2015 Apr; 114(4):1377-85. PubMed ID: 25604672
[TBL] [Abstract][Full Text] [Related]
10. Role of FcγRIII in the nasal cavity of BALB/c mice in the primary amebic meningoencephalitis protection model.
Rojas-Ortega DA; Rojas-Hernández S; Sánchez-Mendoza ME; Gómez-López M; Sánchez-Camacho JV; Rosales-Cruz E; Yépez MMC
Parasitol Res; 2023 May; 122(5):1087-1105. PubMed ID: 36913025
[TBL] [Abstract][Full Text] [Related]
11. Iron-Binding Protein Degradation by Cysteine Proteases of Naegleria fowleri.
Martínez-Castillo M; Ramírez-Rico G; Serrano-Luna J; Shibayama M
Biomed Res Int; 2015; 2015():416712. PubMed ID: 26090408
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowleri.
Hara T; Fukuma T
Parasitol Int; 2005 Dec; 54(4):219-21. PubMed ID: 16002330
[TBL] [Abstract][Full Text] [Related]
13. Identification and significance of Naegleria fowleri isolated from the hot spring which related to the first primary amebic meningoencephalitis (PAM) patient in Taiwan.
Tung MC; Hsu BM; Tao CW; Lin WC; Tsai HF; Ji DD; Shen SM; Chen JS; Shih FC; Huang YL
Int J Parasitol; 2013 Aug; 43(9):691-6. PubMed ID: 23665128
[TBL] [Abstract][Full Text] [Related]
14. Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri.
Burri DC; Gottstein B; Zumkehr B; Hemphill A; Schürch N; Wittwer M; Müller N
Microbiology (Reading); 2012 Oct; 158(Pt 10):2652-2660. PubMed ID: 22878396
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial genome and a 60-kb nuclear DNA segment from Naegleria fowleri, the causative agent of primary amoebic meningoencephalitis.
Herman EK; Greninger AL; Visvesvara GS; Marciano-Cabral F; Dacks JB; Chiu CY
J Eukaryot Microbiol; 2013; 60(2):179-91. PubMed ID: 23360210
[TBL] [Abstract][Full Text] [Related]
16. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
[TBL] [Abstract][Full Text] [Related]
17. A biochemical comparison of proteases from pathogenic naegleria fowleri and non-pathogenic Naegleria gruberi.
Serrano-Luna J; Cervantes-Sandoval I; Tsutsumi V; Shibayama M
J Eukaryot Microbiol; 2007; 54(5):411-7. PubMed ID: 17910685
[TBL] [Abstract][Full Text] [Related]
18. Primary amoebic meningoencephalitis in an infant.
Mittal N; Mahajan L; Hussain Z; Gupta P; Khurana S
Indian J Med Microbiol; 2019; 37(1):120-122. PubMed ID: 31424023
[TBL] [Abstract][Full Text] [Related]
19. Identification of differential protein recognition pattern between Naegleria fowleri and Naegleria lovaniensis.
Gutiérrez-Sánchez M; Carrasco-Yepez MM; Herrera-Díaz J; Rojas-Hernández S
Parasite Immunol; 2020 Jun; 42(6):e12715. PubMed ID: 32191816
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis of Naegleria fowleri cathepsin B paralogs: important drug targets.
Aurongzeb M; Haq SA; Rashid Y; Ahmed Naqvi SH; Hussain SI; Rehman AU; Kaleem I; Bashir S
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3162-3172. PubMed ID: 33928602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
